Nivolumab Plus Temozolomide for Neuroendocrine Neoplasms
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A phase 2 clinical trial of nivolumab and temozolomide for neuroendocrine neoplasms
Clin. Cancer Res 2022 Oct 18;[EPub Ahead of Print], DH Owen, B Benner, L Wei, V Sukrithan, A Goyal, Y Zhou, C Pilcher, SA Suffren, G Christenson, N Curtis, M Jukich, E Schwarz, H Savardekar, R Norman, S Ferguson, B Kleiber, R Wesolowski, WE Carson, GA Otterson, CF Verschraegen, MH Shah, B KondaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.